Central Iowa IA
Is today the day? Pfizer's COVID-19 vaccine reaches final review.
The 17-member Vaccines and Related Biological Products Advisory Committee will consider whether Pfizer's COVID-19 vaccine should be authorized in U.S. |!| Des Moines
